The global Pet Supplements Market is set for steady expansion as pet owners worldwide continue investing in premium, science-backed companion animal nutrition. "According to a recent study by SNS Insider, the global Pet Supplements Market size valued at USD 3.14 billion in 2025, is anticipated to grow to USD 5.81 billion by 2035, registering a CAGR of 6.34% over the 2026-2035 forecast period."

There have been tremendous changes within pet supplement formulation and clinical validation over time due to which many manufacturers who aim at improving efficacy can take advantage of this trend. This includes the need for more palatable, clinically supported products that will provide pet owners with the ability to trust supplementation claims. This applies in situations where pet supplements are used across preventive care, digestive health, and joint health applications.

Manufacturers are constantly working hard to ensure that their pet supplement products perform better than before in order to meet various needs of pet owners worldwide.

To Get Detailed Insights on the Pet Supplements Market – Request a Sample Report

Clinically Validated Companion Animal Nutrition Ecosystems Create New Demand

The pet supplements market has evolved from basic multivitamin offerings to more advanced probiotic and personalized microbiome-based use cases. The growing investment in clinical research, palatability engineering, and veterinary channel development for a variety of applications has required the development of more efficient and reliable formulation systems.

New formulations of pet supplements will enhance palatability, offer clinical believability, and give access to more veterinary channels. As a result, it is easier for manufacturers to be more successful in marketing their products.

Pet supplement companies, veterinary pharma companies, and consumer packaged goods acquirers are cooperating now because of the rising interest in the development of future solutions in premium companion animal nutrition.

Key Market Findings Highlight High-Growth Segments

The dog segment dominated the Pet Supplements Market with a market revenue share of 68% in 2025, driven by higher supplement adoption, a large dog-owning population, and broad product availability.

The fastest-growing category is expected to be cats, supported by increasing pet humanization and growing awareness of feline health, nutrition, and preventive care.

According to types, the highest market revenue share is attributed to multivitamins (27% in 2025), based on their multiple health benefits and higher consumption rate among consumers. Prebiotics & Probiotics will be the fastest-growing market segment due to growing awareness about digestive health and immunity benefits.

Conventional supplements hold a 72% market revenue share in 2025, due to their wide availability and higher consumer acceptance. Organic supplements will be the fastest-growing market segment, owing to the rising trend among pet owners to opt for organic and sustainable pet supplements.

In terms of distribution, offline channels account for a 61% revenue share in 2025, including veterinary clinics, pet specialty stores, and retail stores. Online channels will be the fastest-growing distribution segment up to 2035, owing to easy shopping through e-commerce platforms, variety of products offered, discounts, and direct to consumer sales.

Palatability, Clinical Credibility, and Personalization Gain Importance

In this regard, pet owners have been looking at supplements that would make their pet's health support more palatable and require less compliance friction and be more clinically credible.

Innovation in soft chew formulation, clinical research publication, and personalized microbiome formulation has been making it possible for companies to come up with products that can meet increasingly demanding pet health expectations. In addition to that, increasing emphasis on veterinary channel expansion and ingredient transparency is also making it possible for companies to find solutions that optimize pet owner trust.

Such trends are likely to become even more prominent in the future.

North America Emerges as the Largest Market with 43.37% Revenue Share Amid Rising Pet Humanization

The North America region represented 43.37% share of global market revenue in 2025 and was the largest regional market, owing to rising pet humanization and increasing disposable income. In addition, Asia Pacific is expected to be the fastest-growing market during the forecast period, propelled by rapidly growing pet ownership and applications across the region's fast-growing e-commerce industries.

On the other hand, Europe represented a meaningful share of global market revenue in 2025, aided by growing veterinary channel expansion and strong consumer awareness of pet health and wellness.

Leading Companies Drive Innovation and Competition

The environment continues to stay very dynamic since players continue innovating on products and technologies as well as forming partnerships in order to enhance their position in the industry.

Some of the major companies that operate in the global pet supplements market are Nestlé Purina PetCare Company, Mars Petcare Inc., Hill's Pet Nutrition Inc., Zoetis Inc., Virbac S.A., Bayer AG, Nutramax Laboratories Inc., Zesty Paws, PetIQ Inc., and Elanco Animal Health Incorporated.

An SNS Insider Analyst Parry Kardani commented, "The rapid commercialization of clinically validated, palatable pet supplements is creating unprecedented demand for high-quality companion animal nutrition products. Manufacturers that successfully combine clinical credibility, palatability engineering, veterinary channel access, and advanced formulation capabilities will be best positioned to capitalize on emerging opportunities across preventive care, digestive health, and joint health applications."

Parry Kardani

Parry Kardani is an experienced Research Analyst specializing in market research, business intelligence, and strategic industry analysis within the Healthcare sector. She possesses strong expertise in evaluating healthcare technologies, medical devices, diagnostics, pharmaceuticals, biotechnology, digital health solutions, healthcare IT, and emerging therapeutic innovations across global markets. Her core competencies include market sizing and forecasting, competitive benchmarking, value chain and supply chain analysis, regulatory and reimbursement assessment, technology evaluation, demand-supply analysis, and healthcare industry trend monitoring. With a strong analytical approach and deep understanding of healthcare market dynamics, she supports organizations in identifying growth opportunities, assessing competitive landscapes, and making informed strategic decisions in the rapidly evolving healthcare ecosystem.